Lectin pathway of complement activation in a Polish woman with MASP-2 deficiency

被引:11
作者
Olszowski, Tomasz [1 ]
Poziomkowska-Gesicka, Iwona [2 ]
Jensenius, Jens Christian [3 ]
Adler, Grazyna [4 ]
机构
[1] Pomeranian Med Univ, Dept Hyg Epidemiol & Publ Hlth, PL-70210 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Clin Allergol, PL-70210 Szczecin, Poland
[3] Aarhus Univ, Dept Biomed, Aarhus, Denmark
[4] Pomeranian Med Univ, Dept Gerontobiol, PL-70210 Szczecin, Poland
关键词
Lectin pathway; MASP-2; deficiency; MASP2 D120G homozygosity; MANNAN-BINDING-LECTIN; SERINE-PROTEASE-2; CHILDREN; GENE; DISEASE; SYSTEM; ADULTS;
D O I
10.1016/j.imbio.2013.10.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:261 / 262
页数:2
相关论文
共 50 条
  • [41] MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humans
    Zhang, Ming
    Hou, Yunfang Joan
    Cavusoglu, Erdal
    Lee, Daniel C.
    Steffensen, Rudi
    Yang, Liming
    Bashari, Daniel
    Villamil, Jose
    Moussa, Motaz
    Fernaine, George
    Jensenius, Jens C.
    Marmur, Jonathan D.
    Ko, Wilson
    Shevde, Ketan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 166 (02) : 499 - 504
  • [42] Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway
    Hayashi, Manabu
    Machida, Takeshi
    Ishida, Yumi
    Ogata, Yusuke
    Omori, Tomoko
    Takasumi, Mika
    Endo, Yuichi
    Suzuki, Toshiyuki
    Sekimata, Masayuki
    Homma, Yoshimi
    Ikawa, Masahito
    Ohira, Hiromasa
    Fujita, Teizo
    Sekine, Hideharu
    JOURNAL OF IMMUNOLOGY, 2019, 203 (06) : 1411 - 1416
  • [43] A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway
    Takahashi, M
    Endo, Y
    Fujita, T
    Matsushita, M
    INTERNATIONAL IMMUNOLOGY, 1999, 11 (05) : 859 - 863
  • [44] High Levels of Complement Activating Enzyme MASP-2 Are Associated With the Risk of Future Incident Venous Thromboembolism
    Damoah, Christabel Esi
    Snir, Omri
    Hindberg, Kristian
    Garred, Peter
    Ludviksen, Judith K.
    Braekkan, Sigrid K.
    Morelli, Vania M.
    Mollnes, Tom Eirik
    Hansen, John-Bjarne
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42 (09) : 1186 - 1197
  • [45] PROTEINS OF THE LECTIN PATHWAY OF THE COMPLEMENT SYSTEM ACTIVATION: IMMUNOBIOLOGICAL FUNCTIONS, GENETICS AND INVOLVEMENT IN THE PATHOGENESIS OF HUMAN DISEASES
    Smolnikova, M., V
    Tereshchenko, S. Yu
    INFEKTSIYA I IMMUNITET, 2022, 12 (02): : 209 - 221
  • [46] Review of the unique and dominant lectin pathway of complement activation in agnathans
    Lu, Jiali
    Zhao, Zhisheng
    Li, Qingwei
    Pang, Yue
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2023, 140
  • [47] The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification
    Harboe, Morten
    Garred, Peter
    Karlstrom, Ellen
    Lindstad, Julie K.
    Stahl, Gregory L.
    Mollnes, Tom Eirik
    MOLECULAR IMMUNOLOGY, 2009, 47 (2-3) : 373 - 380
  • [48] Genetic influences on Mannan-binding lectin (MBL) and Mannan-binding lectin associated serine protease-2 (MASP-2) activity
    Sorensen, Grith L.
    Petersen, Inge
    Thiel, Steffen
    Fenger, Mogens
    Christensen, Kaare
    Kyvik, Kirsten O.
    Sorensen, Thorkild I. A.
    Holmskov, Uffe
    Jensenius, Jens Christian
    GENETIC EPIDEMIOLOGY, 2007, 31 (01) : 31 - 41
  • [49] Mechanisms of complement lectin pathway activation and resistance by trypanosomatid parasites
    Cestari, Igor
    Evans-Osses, Ingrid
    Schlapbach, Luregn J.
    de Messias-Reason, Iara
    Ramirez, Marcel I.
    MOLECULAR IMMUNOLOGY, 2013, 53 (04) : 328 - 334
  • [50] Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours
    St Swierzko, Anna
    Szala, Agnieszka
    Sawicki, Sambor
    Szemraj, Janusz
    Sniadecki, Marcin
    Sokolowska, Anna
    Kaluzynski, Andrzej
    Wydra, Dariusz
    Cedzynski, Maciej
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (11) : 1129 - 1140